10 research outputs found
Past, Present, and Future of Naturally Occurring Antimicrobials Related to Snake Venoms
This review focuses on proteins and peptides with antimicrobial activity because these biopolymers can be useful in the fight against infectious diseases and to overcome the critical problem of microbial resistance to antibiotics. In fact, snakes show the highest diversification among reptiles, surviving in various environments; their innate immunity is similar to mammals and the response of their plasma to bacteria and fungi has been explored mainly in ecological studies. Snake venoms are a rich source of components that have a variety of biological functions. Among them are proteins like lectins, metalloproteinases, serine proteinases, L-amino acid oxidases, phospholipases type A2, cysteine-rich secretory proteins, as well as many oligopeptides, such as waprins, cardiotoxins, cathelicidins, and β-defensins. In vitro, these biomolecules were shown to be active against bacteria, fungi, parasites, and viruses that are pathogenic to humans. Not only cathelicidins, but all other proteins and oligopeptides from snake venom have been proteolyzed to provide short antimicrobial peptides, or for use as templates for developing a variety of short unnatural sequences based on their structures. In addition to organizing and discussing an expressive amount of information, this review also describes new β-defensin sequences of Sistrurus miliarius that can lead to novel peptide-based antimicrobial agents, using a multidisciplinary approach that includes sequence phylogeny
Antimicrobial Activity of Snake β-Defensins and Derived Peptides
β-defensins are antimicrobial peptides presenting in vertebrate animals. They participate in innate immunity, but little is known about them in reptiles, including snakes. Although several β-defensin genes were described in Brazilian snakes, their function is still unknown. The peptide sequence from these genes was deduced, and synthetic peptides (with approximately 40 amino acids and derived peptides) were tested against pathogenic bacteria and fungi using microbroth dilution assays. The linear peptides, derived from β-defensins, were designed applying the bioisosterism strategy. The linear β-defensins were more active against Escherichia coli, Micrococcus luteus, Citrobacter freundii, and Staphylococcus aureus. The derived peptides (7–14 mer) showed antibacterial activity against those bacteria and on Klebsiella pneumoniae. Nonetheless, they did not present activity against Candida albicans, Cryptococcus neoformans, Trychophyton rubrum, and Aspergillus fumigatus showing that the cysteine substitution to serine is deleterious to antifungal properties. Tryptophan residue showed to be necessary to improve antibacterial activity. Even though the studied snake β-defensins do not have high antimicrobial activity, they proved to be attractive as template molecules for the development of antibiotics
Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of K-V Channels
Crotamine, a 5-kDa peptide, possesses a unique biological versatility. Not only has its cell-penetrating activity become of clinical interest but, moreover, its potential selective antitumor activity is of great pharmacological importance. In the past, several studies have attempted to elucidate the exact molecular target responsible for the crotamine-induced skeletal muscle spasm. The aim of this study was to investigate whether crotamine affects voltage-gated potassium (K-V) channels in an effort to explain its in vivo effects. Crotamine was studied on ion channel function using the two-electrode voltage clamp technique on 16 cloned ion channels (12 K-V channels and 4 Na-V channels), expressed in Xenopus laevis oocytes. Crotamine selectively inhibits K-V 1.1, K-V 1.2, and K-V 1.3 channels with an IC50 of similar to 300 nM, and the key amino acids responsible for this molecular interaction are suggested. Our results demonstrate for the first time that the symptoms, which are observed in the typical crotamine syndrome, may result from the inhibition of K-V channels. The ability of crotamine to inhibit the potassium current through K-V channels unravels it as the first snake peptide with the unique multifunctionality of cell-penetrating and antitumoral activity combined with K-V channel-inhibiting properties. This new property of crotamine might explain some experimental observations and opens new perspectives on pharmacological uses.Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/07128-7]Programa de Apoio a PosgraduacaoCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Government)Programa de Apoio a Pos-graduacao-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Government)Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico [490194/2007-9]Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0257.08, G.0330.06]Fonds Wetenschappelijk Onderzoek VlaanderenOnderzoeks Traject K.U. LeuvenOnderzoeks Traject K.U. Leuven [05-64]Universitaire Attractie Pool 6/31 (Interuniversity Attraction Poles)Universitaire Attractie Pool 6/31 (Interuniversity Attraction Poles
Interaction of the Rattlesnake Toxin Crotamine with Model Membranes
Crotamine is one of the main constituents
of the venom of the South
American rattlesnake <i>Crotalus durissus terrificus</i>. A common gene ancestry and structural similarity with the antimicrobial
β-defensins (identical disulfide bond pattern and highly positive
net charge) suggested potential antimicrobial activities for this
snake toxin. Although crotamine demonstrated low activity against
both Gram-positive and Gram-negative bacteria, a pronounced antifungal
activity was observed against <i>Candida</i> spp., <i>Trichosporon</i> spp., and <i>Cryptococcus neoformans</i>. Crotamine’s selective antimicrobial properties, with no
observable hemolytic activity, stimulated us to evaluate the potential
applications of this polypeptide as an antiyeast or candicidal agent
for medical and industrial application. Aiming to understand the mechanism(s)
of action underlying crotamine antimicrobial activity and its selectivity
for fungi, we present herein studies using membrane model systems
(i.e., large unilamellar vesicles, LUVs, and giant unilamellar vesicles,
GUVs), with different phospholipid compositions. We show here that
crotamine presents a higher lytic activity on negatively charged membranes
compared with neutral membranes, with or without cholesterol or ergosterol
content. The vesicle burst was not preceded by membrane permeabilization
as is generally observed for pore forming peptides. Although such
a property of disrupting lipid membranes is very important to combat
multiresistant fungi, no inhibitory activity was observed for crotamine
against biofilms formed by several <i>Candida</i> spp. strains,
except for a limited effect against <i>C. krusei</i> biofilm